Orion Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Sell
20,383
-191
-0.9% -$22.4K 0.76% 30
2026
Q1
$2.47M Hold
20,574
– – 0.79% 29
2025
Q4
$2.17M Hold
20,574
– – 0.66% 31
2025
Q3
$1.73M Sell
20,574
-600
-3% -$49.4K 0.55% 33
2025
Q2
$1.68M Sell
21,174
-774
-4% -$61.5K 0.59% 32
2025
Q1
$1.97M Sell
21,948
-12
-0.1% -$1.12K 0.81% 28
2024
Q4
$2.18M Hold
21,960
– – 0.87% 29
2024
Q3
$2.49M Hold
21,960
– – 0.97% 23
2024
Q2
$2.72M Buy
+21,960
New +$2.83M 1.08% 20

Other funds holding MRK

Orion Investment Company's MRK Position: Q2 2026 in Review

Orion Investment Company reduced its Merck (MRK) stake by 0.93% in Q2 2026, selling an estimated $22.4K and leaving 20,383 shares worth $2.62M. The position accounts for 0.76% of the portfolio, ranked #30.

Orion Investment Company first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.72M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Orion Investment Company held 20,383 shares of Merck worth $2.62M as of Q2 2026.
  • Orion Investment Company sold 191 Merck shares in Q2 2026, an estimated $22.4K.
  • Merck made up 0.76% of Orion Investment Company's portfolio in Q2 2026, its #30 holding.
  • Orion Investment Company first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • Orion Investment Company's Merck position peaked at $2.72M in Q2 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.